Cargando…
Comparing TIMP-1 and Hsp70 in Blood and Saliva as Potential Prognostic Markers in HNSCC
(1) Background: Currently, there is no clinically used liquid biomarker in head and neck squamous cell carcinoma (HNSCC) patients. One reason could be the limited shedding of tumor material in early disease stages. Molecular diagnostics assessing both blood and especially saliva could potentially im...
Autores principales: | Rinecker, Jakob, Roesch, Romina, Krippgans, Sara, Nieberler, Markus, Stark, Leonhard, Stangl, Stefan, Haller, Bernhard, Fritsche, Kristin, Multhoff, Gabriele, Knopf, Andreas, Winter, Christof, Wollenberg, Barbara, Wirth, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775946/ https://www.ncbi.nlm.nih.gov/pubmed/36551979 http://dx.doi.org/10.3390/biomedicines10123225 |
Ejemplares similares
-
NOTCH1 Intracellular Domain and the Tumor Microenvironment as Prognostic Markers in HNSCC
por: Schmidl, Benedikt, et al.
Publicado: (2022) -
Imaging of Hsp70-positive tumors with cmHsp70.1 antibody-conjugated gold nanoparticles
por: Gehrmann, Mathias K, et al.
Publicado: (2015) -
Protocol for generating monoclonal CRISPR-Cas9-mediated knockout cell lines using RNPs and lipofection in HNSCC cells
por: Geyer, Fabian, et al.
Publicado: (2023) -
Time- and Dose-Dependent Effects of Ionizing Irradiation on the Membrane Expression of Hsp70 on Glioma Cells
por: Fellinger, Helena, et al.
Publicado: (2020) -
7Hsp70 serum levels in pet dogs—a potential diagnostic biomarker for spontaneous round cell tumors
por: Salvermoser, Lukas, et al.
Publicado: (2019)